Key Takeaways
- Barnwell Bio has raised $6 million in seed funding led by Twelve Below, with participation from multiple agtech and venture investors.
- The funding will support expansion across the U.S. poultry belt and further development of the company’s metagenomic insights platform.
- Barnwell Bio’s system provides early warning signals for disease by analyzing the full microbial ecosystem of poultry barns.
- The platform is designed to support biosecurity and profitability amid rising regulatory and disease pressures.
- The founding team previously helped build the U.S. COVID-19 wastewater monitoring infrastructure.
Barnwell Bio Secures Seed Funding to Scale Poultry Biosurveillance Platform
Barnwell Bio, a precision animal health intelligence company, has announced the close of a $6 million seed funding round to scale its metagenomic biosurveillance system for the poultry industry. The round was led by Twelve Below, with participation from Max Ventures, Dorm Room Fund, Banter Capital, Planeteer Capital, AgVentures Alliance, Daybreak Ventures, Alumni Ventures, and AgLaunch Farmers.
The company plans to use the capital to expand its footprint across the U.S. poultry belt, with an initial focus on the Midwest and Southeast, while also investing in the continued development of its proprietary data and analytics capabilities.
Barnwell Bio's Metagenomic Intelligence for Early Disease Detection
Unlike traditional diagnostic tools that test for individual pathogens, Barnwell Bio’s platform analyzes the entire microbial ecosystem within a poultry barn. By processing hundreds of thousands of data points, the system creates a facility-specific “microbiome fingerprint” that can signal emerging disease risks before clinical symptoms appear.
